Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The FDA approved tirzepatide (Zepbound) for chronic weight management in November 2023, making it the second GLP-1 receptor agonist approved specifically for weight management following semaglutide's 2021 Wegovy approval
Wegovy may also lower cholesterol at similar doses to Ozempic since it contains the same active ingredient as Ozempic (semaglutide) but was specifically FDA approved for weight loss
How long will the BCBS coverage exclusion last
It pairs well with: Training and endurance-focused wellness plans Weight-management and metabolic-support routines Performance, recovery, and active lifestyle strategies Storage and Handling Store in a cool, dry place away from direct sunlight Follow sterile handling procedures Keep out of reach of children Use only as directed For intramuscular use only Important Medical Disclaimer This product is intended for use under the supervision of a qualified healthcare professional
two fold) under BSO exposure in presence of 3-AT, and lower GSSG in BSO treated cells uninhibited for catalase (Fig
